Surging Cases Of Mental Illness To Drive Market Growth Is Supporting Development Across The Psychedelic Drugs Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Psychedelic Drugs Market Increase Between 2026 And 2030?

The psychedelic drugs market has seen substantial growth recently. It is forecast to grow from $6.33 billion in 2025 to $7.37 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.4%. The expansion observed in the past can be ascribed to a significant unmet need in depression treatment, initial academic research on psychedelics, various underground and compassionate use cases, the restricted effectiveness of conventional antidepressants, and increasing mental health awareness.

The psychedelic drugs market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $13.67 billion by 2030, driven by a compound annual growth rate (CAGR) of 16.7%. This anticipated growth can be attributed to factors such as new regulatory approvals allowing medical use, increased acceptance among psychiatrists, a broadening range of conditions for which these drugs are indicated, better data on patient recovery, and collaborative ventures between biotechnology firms and healthcare providers. Key trends during this period are expected to involve the wider implementation of psychedelic-assisted therapy programs, an increase in clinical research for various mental health conditions, a greater willingness to embrace alternative psychiatric approaches, clearer regulatory frameworks for controlled substances, and a surge in funding from venture capitalists and pharmaceutical companies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Are The Main Drivers Accelerating The Growth Of The Psychedelic Drugs Market?

The escalating prevalence of mental health conditions is anticipated to drive the expansion of the psychedelic drugs market moving forward. Mental illnesses are defined as health states characterized by alterations in emotion, thought processes, or conduct. These conditions encompass issues such as distress and post-traumatic stress disorder. Psychedelic substances serve as treatments for depression and post-traumatic stress disorder, with consistent use contributing to a reduction in mental illnesses. For example, in November 2023, as per the National Health Service, a UK-based government department, an estimated one in five individuals aged 8 to 25 years were likely to have a mental disorder in 2023, impacting 20.3% of 8 to 16-year-olds, 23.3% of 17 to 19-year-olds, and 21.7% of 20 to 25-year-olds. Hence, the growing incidence of mental illnesses is a key factor propelling the growth of the psychedelic drugs market.

How Does Segment Analysis Break Down The Psychedelic Drugs Market Structure?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Trends Are Influencing The Psychedelic Drugs Market?

Leading companies in the psychedelic drugs market are prioritizing the creation of novel solutions, such as pharmaceutical-grade psilocybin formulations, to improve therapeutic effectiveness, guarantee safety, and broaden treatment possibilities for mental health conditions. A pharmaceutical-grade psilocybin formulation means psilocybin manufactured and standardized to meet pharmaceutical quality, thereby ensuring uniform purity, potency, and safety for medical applications. For example, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, introduced its natural psilocybin capsules in Australia specifically for TRD treatment. With this product release, Optimi Health seeks to offer patients a clinically endorsed treatment alternative, expand its foothold in the Australian mental health market, and accelerate the acceptance of psychedelic-assisted therapies.

Which Industry Players Are Present In The Psychedelic Drugs Market?

Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Access The Complete Psychedelic Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Regional Market Leads The Psychedelic Drugs Market?

North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Psychedelic Drugs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2026, By The Business Research Company

Psychedelic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Neurological Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795